Aim: Hyperlipidemia has been ranked as one of the greatest risk factors contributing to prevalence and severity of coronary heart diseases. The present study has been taken up to evaluate hypolipidemic activity of hydro alcoholic extract of Cardiospermum halicacabum L. leaf, as this plant is widely used by the local healers of South India for treatment of various illnesses.
INTRODUCTION
Lipids play a critical role in almost all aspects of biological life as they are structural components in cells and are involved in metabolic and hormonal pathways. Lipids are naturally occurring molecules from a plant or animal source. Hyperlipidemia is a condition when abnormally high levels of lipids, i.e., fatty acid substances are found in blood. This condition is also called hypercholesterolemia or hyperlipoprotenemia. 1 Hyperlipidemia has been ranked as one of the greatest risk factors contributing for prevalence and severity of coronary heart diseases. Coronary heart disease, stroke, atherosclerosis, and hyperlipidemia are the primary causes of death. The elevation of serum total cholesterol and low-density lipoprotein (LDL) cholesterol has been reported as a primary risk factor for cardiovascular disease. The World Health Organization has reported that cardiovascular diseases are going to be one of the largest cause of death and disability in India by 2020. 2 Hypolipidemic drugs are extensively used for preventing and treatment of cardiovascular diseases. As the long-term consumption of synthetic drugs has been reported for various adverse effects, the researchers have started focusing on plant-based medicines. Many plant species and plant derivatives have been screened and documented for their hypolipidemic action. The advantages of herbal medicines are effectiveness, safety, affordability, and easy acceptability. Cardiospermum halicacabum, L. known as "Balloon vine" or "Love in a puff", is a climbing plant widely distributed in tropical and subtropical Africa and Asia. It is an annual or sometimes perennial climber, commonly found as a weed in farmland. It is mentioned as one among the "Ten Sacred Flowers" of Kerala State in India, collectively known as "Dasapushpam". 3 It is widely used by local healers of southern part of India for treatment of various illnesses and the plant has also been reported for some biological activities including anticonvulsant, analgesic, and anti-inflammatory activities. [4] [5] [6] [7] The present study has been taken up to evaluate the hypolipidemic activity of hydroalcoholic extract of Cardiospermum halicacabum L. leaf, in experimental animals.
MATERIALS AND METHODS

Plant Collection and Extraction
The plant Cardiospermum halicacabum L. was collected from the Western Ghat region (Palghat and Thrissur) of Kerala, India. 
Efficacy Study Design
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A total of 36 Wistar Albino rats of 12 weeks old were randomized and equally divided into six groups. Each group consisted of 6 animals (3 males and 3 females). Control group received standard diet and distilled water; test extract group received 250 mg/kg bwt C. halicacabum L. extract and standard diet; disease control group received only atherodiet; treatment group-low dose received atherodiet with 250 mg/kg bwt C. halicacabum L. extract; treatment group-high dose received atherodiet with 500 mg/kg bwt C. halicacabum L. extract; and SD group received atherodiet with 5 mg/kg bwt Atorvastatin (Table 1) .
Sample Collection and Biochemical Studies
After 4 weeks of treatment, body weights were measured and blood samples were collected by retro orbital route after overnight fasting of the animals for the study of biochemical parameters. Serum was evaluated for fasting blood sugar, glycated hemoglobin (HbA1C) level, total lipids, total cholesterol, triglycerides, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, very-low-density lipoprotein (VLDL), and phospholipids level. The liver function tests [(serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP)] and renal function tests (urea, creatinine) were also carried out.
Atherogenic Index
14
The Atherogenic Index was calculated as per the standard protocol. Atherogenic Index = (LDL + VLDL)/HDL
Coronary Risk Index 15
Coronary Risk Index was calculated by the method of Alladi et al. 15 Coronary Risk Index = (Total cholesterol)/HDL 
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Histopathological Studies
At the end of experiment, animals were sacrificed as per standard euthanasia procedure and the organs liver, kidney, and heart were collected for histopathological examinations.
Statistical Analysis
One-way analysis of variance (ANOVA) with post hoc analysis was carried out. Number of observations (N), group means, standard error mean, and standard deviations were calculated. The data were examined using normality tests. Once the data showed normal distribution, it was tested for heterogeneity of variances. One-way ANOVA was performed once the variances are homogeneous. Dunnett's test was applied to compare the dose groups over the control arm. If the data were not distributed normally and heterogeneous, the KruskalWallis test was done.
RESULTS AND DISCUSSION
The hypolipidemic activity of hydroalcoholic extract of C. halicacabum L. leaf was carried out in Wistar Albino rats using atherodiet. The % body weight gain of the healthy control group showed 50.54% and disease control group is found to be 67.84%. The body weight gain was found to be 52.72 and 49.81% for treatment group-low dose and high dose respectively. The % body weight gain of SD group (Atorvastatin treated) showed 46.55%. The study showed that the body weight gain was found to be less in the extract treated groups and SD group as compared with disease control group. The details of body weight gain have been documented in Graph 1. The study showed that there are no significant changes in glucose, HbA1C, urea, creatinine, and uric acid levels among treatment groups and SD group when compared with healthy control and disease control (Graphs 2 and 3). The extract control group showed there was no significant changes in the lipid profile as compared with healthy control (p > 0.05). The lipid profile parameters cholesterol, LDL, VLDL, triglyceride levels were found to be significantly (p < 0.05 and p < 0.01) elevated in disease control group when compared with healthy control group. As such, there were significant increase of total lipids, phospholipids, Atherogenic Index, and Coronary Risk Index factors (p < 0.01) in the disease control group. The treatment groups with C. halicacabum L. leaf extract, i.e., low dose and high dose, showed significant decrease in level of cholesterol, LDL, VLDL, triglyceride levels, total lipids, phospholipids, Atherogenic Index, and Coronary Risk Index factors as compared with disease control group (p < 0.01). It was noted that the lipid profile parameters of the treatment group-low dose were not attaining the normal range of healthy control group but there were significant improvement of the same as compared with disease control group. The lipid profile of the treatment group-high dose (500 mg/kg bwt) showed that there were significant improvement as compared with disease control and the values are normal and comparable with healthy control. The Atorvastatin-treated SD group showed significant decrease of lipid profile as compared with disease control group and the values are in normal range in healthy control. These details have been documented in Table 1 and Graphs 4 to 6. The evaluations of liver function tests, including total protein, albumin, globulin, SGOT, SGPT, ALP and total protein levels, were found to be normal in all the groups, and there were no significant changes observed when compared with healthy control (Table 2 and Graphs 7 and 8).
Histopathology
No major histopathological changes were observed in liver, kidney, and heart tissue samples when compared with healthy control (Figs 1 to 6) . So, the study proved the safety of the test extract at the prescribed dosages.
CONCLUSION
Hyperlipidemia is a condition of elevated levels of lipid profile in the blood. Hyperlipidemic condition increases the risk for cardiovascular diseases and stroke. The research on development of plant-based hypolipidemic drugs is going on all over the world on priority basis. The present study has been carried out for evaluating hypolipidemic activity of hydroalcoholic extract of C. halicacabum L. leaf in experimental animals. The experiment was carried out in atherodiet-induced hyperlipidemia in Wistar Albino rats. The biochemical parameters, such as lipid profile with Atherogenic Index and Coronary Risk Index, liver function tests, renal function tests, and other metabolic parameters were evaluated. The study showed that the hydroalcoholic extract of C. halicacabum L. leaf has significant hypolipidemic activity in the atherodietinduced hyperlipidemia in Wistar rats. As the plant has shown significant hypolipidemic activity, it may be used for developing of new product as single drug and/or in the formulations of AYUSH system of medicines for management of hyperlipidemia, after ensuring the clinical trials as per the guidelines.
ACKNOWLEDGMENTS
Authors would like to thank the Director General, Central Council for Research in Ayurvedic Sciences, New Delhi, for the Intra Mural Research Project Grant Table 1 : Lipid profile, total lipids, phospholipids, AI, and CRI parameters in Wistar Albino rats during efficacy study 
Groups
Biochemical parameters-lipid profile
Cholesterol (mg/dL) HDL (mg/dL) LDL (mg/dL
JDRAS
Globulin (gm/dL) A/G SGOT (U/L) SGPT (U/L) ALP (U/L))
